Semiotics of apical hypertrophic cardiomyopathy in magnetic resonance Imaging

Introduction. About 0.2 % of the adult population all over the world suffers from hypertrophic cardiomyopathy. Early and timely diagnosis of the apical form of hypertrophic cardiomyopathy remains an urgent medical problem, since the disease has a wide variability of clinical manifestations and often occurs asymptomatic or with symptoms of other heart diseases. Magnetic resonance imaging is an informative method of radiation diagnosis of hypertrophic cardiomyopathy. The aim is improving of radiology diagnostics in applying to the apical form of hypertrophic cardiomyopathy. Materials and methods. 98 patients with apical hypertrophic cardiomyopathy aged 19 to 76 years were еxamined. There were 48 men and 50 women. All subjects were examined by a cardiologist, all patients underwent electrocardiography and echocardiography, 45 patients underwent magnetic resonance imaging (MRI) of the heart. Results. In our study 13 patients had MRI determined the isolated form of apical form of hypertrophic cardiomyopathy, 32 had combined one. 42.2% of the patients with symmetrical hypertrophy of all apical segments had sawtoothed configuration of the LV revealed by MRI. The symptom of left ventricular cavity obliteration was determined in 19 patients. The symptom of LV cavity sequestration was determined in 5 subjects. 5 patients had an aneurysm on the top of the left ventricle, 1 – on the top of the right ventricle. Signs of left ventricular outflow tract obstruction were visualized in 2 patients, intraventricular obstruction at the level of the middle segments of the left ventricle was determined in 5 cases. Akinesis and hypokinesis were detected in areas of fibrous changes (n=21) or in areas of cardiosclerosis (n=2). In 17.8 % of subjects identified non-compacted myocardium, in 3 cases it was combined with apical form of hypertrophic cardiomyopathy. With contrast enhancement in 29 patients, foci (n=22) or zones (n=7) of pathological accumulation of contrast agent were determined, which indicated the replacement of myocardium with fibrous tissue.

1. 2014 ECS Guidelines on diagnosis and management of hypertrophic cardiomyopathy. EHJ. 2014;(35):2733−2779. Doi: 10.1093/eurheartj/ehu284.

2. Daubeney PE, Nugent AW, Chondros P, Carlin JB et al. Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy. Results From a National Population-Based Study. Circulation. 2006;114(24):2671−2678. Doi: 10.1161/CIRCULATIONAHA.106.635128.

3. Bevilacqua LМ, Berul ChI. Familial Hypertrophic Cardiomyopathy Genetics. Molecular Genetics of Cardiac Electrophysiology. 2000;(231):181−194. Doi: 10.1007/978-1-4615-4517-0.

4. Клинические рекомендации по диагностике и лечению кардиомиопатий (гипертрофическая) // Кардиол. вестн. – 2016. – Т. 11, № 1. – С. 3−23. [Clinical guidelines on diagnosis and treatment of cardiomyopathy (hypertrophic). Kardiologicheskiy vestnik. 2016;11(1):3−23. (In Russ.)].

5. Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. JACC. 2009;(54):201−211. Doi: 10.1016/j.jacc.2009.02.075.

6. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2001;(33):655–670. Doi: 10.1006/jmcc.2001.1340.

7. Шерхова М. Х., Стукалова О. В., Терновой С. К. Апикальная гипертрофическая кардиомиопатия. Диагностика с помощью магнитно-резонансной томографии // REJR. – 2014. – Т. 4, № 3. – С. 77−80. [Sherkhova MH, Stukalova OV, Ternovoy SK. Apical hypertrophic cardiomyopathy. Diagnosis by magnetic resonance imaging. REJR. 2014;4(3):77−80. (In Russ.)].

8. Maron BJ. Hypertrophic cardiomyopathy systematic review. JAMA. 2002;(287):1308−1320. Doi: 10.1001/jama.287.10.1308.

9. Reddy V, Korcarz C, Weinert L et al. Apical. hypertrophic cardiomyopathy. Circulation. 1998;98(21):2354. Doi: 10.1161/01.CIR.98.21.2354.

10. Dastidar AG, Singhal P, Venuti G et al. Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM). JCMR. 2016;18(1):269. Doi: 10.1186/1532-429X-18-S1-P269.

11. Hamada М, Takamura Y, Otani T et al. Left ventricular noncompaction mimicking hypertrophic obstructive cardiomyopathy. Int. J. Cardiol. 2016;(220):825–827. Doi: 10.1016/j.ijcard.2016.06.278.

12. Maron BJ, McKenna WJ, Danielson GK et al. ACC/ ESC Expert Consensus Document on Hypertrophic Cardiomyopathy. JACC. 2003;42(9):1687–1713. Doi: 10.1016/S0735-1097(03)00941-0.

13. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart. 2004;(90):645−649. Doi: 10.1136/hrt.2003.014969.